South Korea · Delayed Price · Currency is KRW SCL Science Statistics
Total Valuation
SCL Science has a market cap or net worth of KRW 89.12 billion. The enterprise value is 116.57 billion.
| Market Cap | 89.12B |
| Enterprise Value | 116.57B |
Important Dates
The next estimated earnings date is Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SCL Science has 34.01 million shares outstanding. The number of shares has increased by 56.09% in one year.
| Current Share Class | 34.01M |
| Shares Outstanding | 34.01M |
| Shares Change (YoY) | +56.09% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 1.78% |
| Owned by Institutions (%) | n/a |
| Float | 15.61M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.92 |
| PB Ratio | 3.32 |
| P/TBV Ratio | 94.16 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 129.89 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.82 |
| EV / EBITDA | 34.26 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.63, with a Debt / Equity ratio of 1.10.
| Current Ratio | 0.63 |
| Quick Ratio | 0.49 |
| Debt / Equity | 1.10 |
| Debt / EBITDA | 9.84 |
| Debt / FCF | -1,600.65 |
| Interest Coverage | -0.32 |
Financial Efficiency
Return on equity (ROE) is -14.54% and return on invested capital (ROIC) is -1.08%.
| Return on Equity (ROE) | -14.54% |
| Return on Assets (ROA) | -0.83% |
| Return on Invested Capital (ROIC) | -1.08% |
| Return on Capital Employed (ROCE) | -2.25% |
| Weighted Average Cost of Capital (WACC) | 7.30% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.44 |
| Inventory Turnover | 13.90 |
Taxes
| Income Tax | -634.07M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -4.03% in the last 52 weeks. The beta is 0.52, so SCL Science's price volatility has been lower than the market average.
| Beta (5Y) | 0.52 |
| 52-Week Price Change | -4.03% |
| 50-Day Moving Average | 2,099.88 |
| 200-Day Moving Average | 2,055.53 |
| Relative Strength Index (RSI) | 62.69 |
| Average Volume (20 Days) | 135,838 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SCL Science had revenue of KRW 30.50 billion and -3.38 billion in losses. Loss per share was -73.81.
| Revenue | 30.50B |
| Gross Profit | 7.00B |
| Operating Income | -920.62M |
| Pretax Income | -4.47B |
| Net Income | -3.38B |
| EBITDA | 2.99B |
| EBIT | -920.62M |
| Loss Per Share | -73.81 |
Balance Sheet
The company has 4.70 billion in cash and 29.46 billion in debt, with a net cash position of -24.76 billion or -727.88 per share.
| Cash & Cash Equivalents | 4.70B |
| Total Debt | 29.46B |
| Net Cash | -24.76B |
| Net Cash Per Share | -727.88 |
| Equity (Book Value) | 26.81B |
| Book Value Per Share | 708.91 |
| Working Capital | -14.07B |
Cash Flow
In the last 12 months, operating cash flow was 686.13 million and capital expenditures -704.53 million, giving a free cash flow of -18.40 million.
| Operating Cash Flow | 686.13M |
| Capital Expenditures | -704.53M |
| Depreciation & Amortization | 3.91B |
| Net Borrowing | -845.04M |
| Free Cash Flow | -18.40M |
| FCF Per Share | -0.54 |
Margins
Gross margin is 22.95%, with operating and profit margins of -3.02% and -11.09%.
| Gross Margin | 22.95% |
| Operating Margin | -3.02% |
| Pretax Margin | -14.65% |
| Profit Margin | -11.09% |
| EBITDA Margin | 9.81% |
| EBIT Margin | -3.02% |
| FCF Margin | n/a |
Dividends & Yields
SCL Science does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -56.09% |
| Shareholder Yield | -56.09% |
| Earnings Yield | -3.80% |
| FCF Yield | -0.02% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 30, 2025. It was a forward split with a ratio of 4.
| Last Split Date | Jun 30, 2025 |
| Split Type | Forward |
| Split Ratio | 4 |
Scores
SCL Science has an Altman Z-Score of 0.27 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.27 |
| Piotroski F-Score | 5 |